ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
Not yet recruiting · NCT07320326 · Registry updated 2026-01-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab | TCE-RRMM | Not yet recruiting | Not stated | 2026-01-06 | NCT07320326 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 146 |